MYC and cancer: In neuroblastoma, lung carcinoma, colon adenocarcinoma, and melanoma cells, dual PI3K/BRD4 inhibition by SF2523 contributes to a decrease in c-Myc levels and markedly inhibits the growth and metastasis of cancer cells [84,85].